TMEM126A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.340200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.572000E-01
Normal-vs-Stage2
3.155600E-01
Normal-vs-Stage3
5.874000E-01
Normal-vs-Stage4
4.008000E-01
Stage1-vs-Stage2
3.687800E-01
Stage1-vs-Stage3
6.481800E-01
Stage1-vs-Stage4
7.830000E-01
Stage2-vs-Stage3
9.331800E-01
Stage2-vs-Stage4
6.747800E-01
Stage3-vs-Stage4
7.950200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.658800E-01
Normal-vs-AfricanAmerican
9.348200E-02
Normal-vs-Asian
3.285400E-01
Caucasian-vs-AfricanAmerican
5.374800E-01
Caucasian-vs-Asian
8.923600E-01
AfricanAmerican-vs-Asian
6.197600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.620200E-01
Normal-vs-Female
2.965200E-01
Male-vs-Female
9.992200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.266000E-01
Normal-vs-Age(41-60Yrs)
2.058800E-01
Normal-vs-Age(61-80Yrs)
3.905600E-01
Normal-vs-Age(81-100Yrs)
4.179900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.680800E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.203800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.236110E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.542800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.138600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.750800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.029600E-01
Normal-vs-Daily Drinker
3.551600E-01
Normal-vs-Weekly Drinker
5.682400E-01
Normal-vs-Occasional Drinker
1.439830E-01
Normal-vs-Social Drinker
6.282000E-01
Non Drinker-vs-Daily Drinker
3.666800E-01
Non Drinker-vs-Weekly Drinker
8.233600E-01
Non Drinker-vs-Occasional Drinker
1.072780E-01
Non Drinker-vs-Social Drinker
8.041800E-01
Daily Drinker-vs-Weekly Drinker
2.993000E-01
Daily Drinker-vs-Occasional Drinker
4.954600E-01
Daily Drinker-vs-Social Drinker
2.931400E-01
Weekly Drinker-vs-Occasional Drinker
6.585700E-02
Weekly Drinker-vs-Social Drinker
9.782800E-01
Occasional Drinker-vs-Social Drinker
7.021900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.383610E-01
Normal-vs-Grade 2
1.610220E-02
Normal-vs-Grade 3
2.455900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.913500E-02
Grade 1-vs-Grade 3
1.163240E-01
Grade 1-vs-Grade 4
1.383610E-01
Grade 2-vs-Grade 3
7.441000E-01
Grade 2-vs-Grade 4
1.610220E-02
Grade 3-vs-Grade 4
2.455900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.171200E-01
Normal-vs-NonDiabetic
3.120800E-01
Diabetic-vs-NonDiabetic
2.661400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.051450E-01
Normal-vs-NoPancreatitis
3.872400E-01
Pancreatitis-vs-NoPancreatitis
5.426800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.120400E-01
Normal-vs-N1
3.601000E-01
N0-vs-N1
2.989000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.546400E-02
Normal-vs-TP53-NonMutant
5.927200E-01
TP53-Mutant-vs-TP53-NonMutant
3.53060000000127E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
